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Bio: Dr. John Cai is Director of CEIBS Centre for Health Care 
Management and Policy and Adjunct Professor of Economics at China 
Europe International Business School (CEIBS). He has been involved in 
teaching, research and consulting work at university, consulting company 
and government in the field of health economics and health policy over 
twenty years. He has published extensively in the areas of health economics 
and health policy, social security, labor and employment, and public 
finance in various academic journals. He has participated in the design, 
implement and evaluation of the first comprehensive health care reform 
plan (Massachusetts) in the U.S. and has also actively involved in the 
design of recent national health care reform plan in China. 
 
Professor Cai was cofounders and the Director of the Institute of Economic 
Development at East China University of Science and Technology 
(Shanghai) (1987-1990) and the first Chair at Department of Public 
Economics at Fudan University (2006-2009). Professor Cai has received 
many awards for both research and teaching, for example, 1990 Sun Yie-
fang National Economic Science Prizes-Best Paper Award, 2002 Most Outstanding Abstract Award by 
Academy for Health Services research and Health Policy Annual Research Meeting in Washington D.C., and 
2009 Excellent Paper Award from Shanghai Social Science Annual Conference. Professor Cai received his 
Ph.D. in Public Policy from the Heller School for Social Policy and Management, Brandeis University in 






1. Experience in US and China 
Lingling: Hello, Professor Cai! I’m very happy to have the opportunity to interview you in the New 
Year, as a representative of the China Health Policy and Management Society (CHPAMS). I 
understand that about ten years ago you started to develop your career in China, what was your 






Dr. Cai: I received my Doctorate in Health Policy in the U.S. back in 1996. I worked for a 
healthcare consulting firm for three years and in 1999 joined the Massachusetts Department of 
Health and Human Services (MDHHS). At the time, there were not that many (Chinese) scholars 
working in soft science fields such as policy. I continued my work at the MDHHS’ policy 
department for more than 10 years, focusing on health financing policy. I was responsible for 
hospital data in the entire Massachusetts, as well as Medicaid pricing policy. In addition, I had a 
hand in the research and design of the healthcare reform by the then governor Mitt Romney, so I 
was familiar with the US healthcare reform policy debate. After the SARS outbreak in 2003, I 
started to pay more attention to the domestic situation in China and began working in China in 
2006. From 2006 to 2009, I was appointed as Chair of the Department of Public Economics, 
School of Economics at my Alma Mater, Fudan University. Even though that was a fulltime job, I 
spent only about 2 to 3 months a year in China, with the majority of my time still in the States. 
Towards the end of my appointment, right around 2009, China started the first round of the new 
healthcare system reform, with 6 agencies providing reform plans, an even split between domestic 
and foreign entities. The three domestic entities were Peking University, Fudan University, and the 
Development Research Center of the State Council. I participated in the drafting and discussion of 
the Fudan University reform plan. To sum it up, I have first-hand experience in both US’s and 
China’s health care system reform. I left Fudan University in 2009 and started an adjunct position 
at Shanghai University of Finance and Economics, until May 2012 when I finally took the full-time 
position at the Chinese Europe International Business School (CEIBS). 
 





2003 年 SARS 之后我开始关注国内的情况，2006年开始有回国工作的经历，先是 2006-
2009 年，我在我的母校复旦大学经济学院任公共经济系主任，虽是全职的职位但一年只有
2-3 个月时间在国内。那时主要的时间还是在美国，不过那段经历正好赶上国内 2009 年新
一轮的医改，当时是 6 家机构提供方案，国内国外各三家，国内是北大、复旦和国务院发
展研究中心，我参加了复旦医改方案的起草和讨论。总的来说，我对两国医改有些第一手
的经历，还是比较熟悉的。09 年后我离开复旦，在上海财经大学有过兼职，直到 2012 年 5
月我才算正式全职的回到了目前就职的中欧国际工商学院工作。 
 
Lingling: Comparing your experience in the two countries, what was your most striking impression 








Dr. Cai: The most striking impression is that healthcare reform is extremely difficult for both 
countries, because a lot of interest groups are involved, both countries have large populations, and 
healthcare reform itself is complex. The countries’ culture, history, and structures, however, are 
different and quite distinct. On a personal level, it’s difficult for an immigrant to integrate into the 
mainstream American society, because of the language and culture barriers. Also, the U.S. has 
pretty mature systems for all aspects of the society, with limited space for professional 
development. For me, working in China definitely gave me more room to develop professionally. 
Also, China lacks professionals with our educational and working background, with knowledge of 
both China and the U.S. With my training and extensive experience in economics and health care, I 
was able to push more much more changes in China than in the U.S., bringing more needed 
changes.  This aspect of my work in China is quite rewarding. My three years in CEIBS was 
especially rewarding. CEIBS is different from traditional universities. The institution provided me 
with a very good working environment, gave me a lot of freedom to explore the areas that interest 















2. Health System Reform(s) 




Dr. Cai: My participation in China’s health system reform was rather indirect, mostly through 
publishing articles, accepting interviews, as well as organizing meetings that might be able to bring 
about changes. I didn’t participate directly in the decision making process. My most direct 
involvement in decision making was two years ago when I participated in Vice Premier Liu 
Yangdong’s panel with ten experts at Zhongnanhai.  I also participated in the meetings and projects 
ran by the National or local Health and Family Planning Commissions. Since CEIBS is a business 
school, we have the closest connection with the healthcare industry. We provide trainings to 
hospital CEOs and senior business executives. On the policy side, every quarter in the last four 
years we conducted a round table meeting with representatives from government, academia, and 
industry, discussing sizzling issues and making recommendations on certain topics. After the 














Lingling: What are the biggest obstacles for health reform in both countries? What lessons can they 




Dr. Cai: Interest groups are the biggest obstacles for health care reforms in both countries. In the 
US, health care reform plans are prepared carefully and in great details, with specifics spelled out, 
making the reform plans easy to implement. In China, healthcare reform plans were drafted in 
broad strokes, making them difficult to implement and leading to disagreements between 
stakeholders. Both countries have their advantages and disadvantages. In China, government can 
have a relatively strong hand in implementing policies. I was impressed that once a policy has 
gained the government’s support, then the government will take measures to ensure the 
implementation of the policy. One example would be the universal health coverage; it was 
implemented quickly and thoroughly. The U.S. operates under a checks-and-balances system that 
moves much slower. In addition, China has some industries that have advanced quickly in the past 
few years, such as the internet and mobile health technologies, narrowing the gap between China 
and the western countries, in some cases even gaining the lead position. The gap between the two 
countries’ medical technological innovations might very well shrink.  
(Interviewer’s note: Dr. Cai served as the editor of "The Worldwide Health System Reforms", 
















3. Current Focus and Activities 




Dr. Cai: We are involved in all allied health areas. Our business school focuses on many 
innovative medical treatment models such as mobile health, e-health, etc. We write up case 




summaries for these models, exchange our ideas through various meetings, and collect all the 
relevant writings into books, with the hope to facilitate communication within the health care field 
and encourage innovation. We have also constructed a China Healthcare Innovation Platform, 
abbreviated in English as CHIP and in Chinese as “Qi2 Pu3.” With this, we hope to develop an 
award for the Chinese health industry that’s in the same vein as the Oscars. Two years ago, we held 
an awards ceremony. We selected 3 to 4 nominees per category, then field experts chose the 
awardee, followed by discussion of the nominated projects. This is a biennial awards event, and 
this year is an awards year. Last year, we also did road shows of some innovative cases. We 
compiled reports and case studies released in 2015 and published the “2015 China Healthcare 
Industry Innovation Platform Blue Book.” We welcome international students and scholars to 
participate in these activities. We have established two WeChat accounts: one for the innovative 
platform (CHIP20140720) and one for health care policy (cchmp2012). You can follow our 





平台 (China Healthcare Innovation Platform)”，英文简称为 CHIP，中文为“奇璞”，我们希
望以此打造一个中国健康行业的奥斯卡奖。前年我们举办了一个颁奖活动，类似于奥斯卡









4. Opportunities and CollaborationL 
Lingling: I have noticed that under your leadership, CEIBS has been active in Chinese health 
industry innovation. Our organization, China Health Policy and Management Society, assembled a 
lot of young scholars, both in China and overseas. Can you talk about opportunities that exist in 






Dr. Cai: China’s health industry is in the take-off stage. In October 2013, the State Council’s 
Directive No. 40 (on promoting the development of China’s health service industry), suggested that 
China’s leaders began to view the health industry as an important growth field. Although the health 
sector accounts for less than 6% of China’s GDP, it was projected to account for an estimated 9-
10% of GDP by a conservative forecast. Even though the growth rate of China’s GDP has slowed, 
the health industry has been growing faster and faster, suggesting that there are considerable 
opportunities in the industry, be it research or industry development. The health care industry is a 
hot field for investment, attracting a lot of investors with deep pockets. These investments can 
create opportunities in research, teaching, and expanding the personnel pool. China lacks qualified 




teaching institutions. There is also a lack of physicians and nurses. The health care industry is 
quickly taking off, but it is facing a shortage of talents. This gap in talent provides a great 
opportunity for young professionals with education and experience in this field. There will be many 
opportunities to develop a career in either or both of the countries. 
 
从宏观来讲，中国医疗行业处于一个起飞阶段，2013 年 10 月国务院有个 40 号文件（关于
促进中国健康服务业发展），以这个文件为标志，中国的顶层设计开始确定健康行业是个
非常重要的增长点和领域，虽然目前健康领域占 GDP 还不到 6%，但是根据保守预测，到













Dr. Cai: Collaboration can be established through joint activities or participation in our events, 
mostly based on people’s shared interests. Our activities will touch on the policy aspects as well as 
industry innovations. We also welcome exchanging case studies, proposing award nominees, and 
participating in the selection of awardees. This year, we will hold several large-scale innovation 
road shows. It’s important to learn about the American business model and their technological 








5. Projections and Suggestions 
Lingling: What are your projections for your career development, as well as CEIBS’ and Chinese 
health system’s development in the next 5 to 10 years? 
 
您对未来 5 到 10 年个人、中欧商学院、以及整个中国医疗体制发展有怎样的期待？ 
  
Dr. Cai: I hope there will be some important reform measures coming out. For the industry, the 
next 5 to 10 years is really a takeoff period. The new healthcare reform has accomplished many 
great things, but not huge improvements. The next 5 to 10 years will likely witness some big 
changes. As for myself, I hope that I can actively participate in this profound change and positively 
influence the outcomes. I believe I can make a relatively large impact in the next five to ten years. 
In addition, we hope that our current work will produce results. Our work so far has received 
recognition and we have stronger influence. We are extremely busy. Although I have to stress that I 
am limited in what I know, a lot of people come to me for advices and consultations. Every year I 




have more than one hundred interviews by journalists. It feels good that I can do my best to bring 
about change, but I think my strength lies in integrating resources and building platforms for more 
people. 
 
我希望中国医改会有一些比较重要的改革措施出台，对于这个行业来说，未来的 5 到 10 年
真的是飞跃时期，新医改以来虽然取得了一些成绩，但还没有特别大的促进，我觉得未来 5
到 10 年可能会有一些比较重大的变化。就我个人来说，我只能说希望在这个大的改革趋势











Dr. Cai: I think it is the most important to find an opportunity that will allow the young scholars to 
reach their full potential. From my own experience, I found this opportunity when I was 50 or so, 
so sometimes we have to make long-term preparation. Finding this opportunity could be easy for 
some, but hard for others. But no matter what, everyone needs to be prepared to grab that 
opportunity when it materializes. As a young professional, you would want to do everything 
possible to make your contributions, especially to those matters to public interests. Do not seek 
short-term fame and wealth, but see whether or not your effort will benefit others and the industry. 
Your value becomes apparent through your contribution to others. In other words, being altruistic 














Dr. Cai: My knowledge of CHPAMS is still limited, but I know this organization consists of 
students and scholars who understand both China and the US. So my message is that I hope 
CHPAMS can better bridge the two countries, introducing US experiences to China, propelling 
China’s health reform forward and the development of its healthcare industry. CHPAMS is not 
heard very often within China, so perhaps you can find a way to expand its influence through more 
publications, or by hosting meetings to introduce what you know to China and contribute to 
China’s development. You can start with the small things, and develop your organization step by 
step. 
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我对学会的了解还比较有限，不过知道这个学会的特点是汇集了对中国和美国都了解的学
生学者，所以我的寄语就是希望学会能更好的发挥桥梁的作用，将美国的一些先进经验传
播到中国去来推动中国的医改、推动中国医疗健康行业的发展，能在这些方面起到更多的
作用。因为相对来说现在在国内听到 CHPAMS 还是比较少的，所以也许可以找到一个好的
方式扩大影响，比如通过你们发表的东西，或者举办会议等将你们所知道的介绍到中国来，
对中国的发展起到积极的作用，可以先从小事上一点点的做起来。 
 
